Targeting BCL-2 overexpression in various human malignancies through NF-κB inhibition by the proteasome inhibitor bortezomib

Bridget N. Fahy, Michael G. Schlieman, Melinda M. Mortenson, Subbulakshmi Virudachalam, Richard J. Bold

Cancer Chemotherapy and Pharmacology · 2005 · 125 citations · 36 references

Concepts

References

36